The percentage of circulating CD14+CD16+ monocyte/macrophage subset was significantly lower in SLE patients compared with healthy controls (6.06 ± 0.53 versus 11.26 ± 0.67, P < 0.001). Here, CD14 is linked to systemic lupus erythematosus.